NCT07098364 2026-01-14ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell LymphomaFred Hutchinson Cancer CenterPhase 1/2 Recruiting33 enrolled
NCT06249191 2025-03-24Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell LymphomaOHSU Knight Cancer InstitutePhase 1/2 Recruiting30 enrolled